Gene Editing Companies Hit Back at Paper That Criticized CRISPR – MIT Technology Review
MIT Technology Review |
Gene Editing Companies Hit Back at Paper That Criticized CRISPR
MIT Technology Review The paper, titled “Unexpected mutations after CRISPR–Cas9 editing in vivo,” triggered a rash of negative headlines after claiming the gene-editing tool caused widespread and unpredictable havoc in the genomes of edited mice, introducing hundreds of … Editas Medicine: Addressing The NegativesSeeking Alpha -$0.41 Earnings Per Share Expected for Intellia Therapeutics Inc (NTLA) This QuarterThe Cerbat Gem |
Drug Discovery & Development |
Startup Raises $10M to Support Stem Cell Platelet Production
Drug Discovery & Development Platelet BioGenesis, a biotech startup developing a process to produce life-saving human platelets from stem cells for therapeutic applications, announced it has successfully raised $10 million in Series A financing. The round was led by Qiming U.S. … |
|
Stem Cell Therapy Potentially Effective in Crohn’s Disease, but Concerns Remain, Review Finds
IBD News Today Stem cell therapy was found to be potentially effective and a possible alternative treatment for patients with refractory active Crohn’s disease, according to a meta–analysis review study. Toxicity remains the most significant barrier to systemic stem … |
Newstalk 106-108 fm |
Irish ‘Supervet’ announces stem cell centre for pets
Newstalk 106-108 fm The centre will be dedicated to rebuilding parts of the skeletal system using stem cell technology married with man-made scaffolds. The centre will be the very first of its kind for animals in Britain where biology and mechanics come together. It will … |
EurekAlert (press release) |
Flaws in a tumor’s genetic mending kit drive treatment response to …
EurekAlert (press release) In an expanded, three-year clinical trial of 86 patients with colorectal and 11 other kinds of cancer that have so-called ‘mismatch repair’ genetic defects, scientists … |
EurekAlert (press release) |
Flaws in a tumor’s genetic mending kit drive treatment response to …
EurekAlert (press release) In an expanded, three-year clinical trial of 86 patients with colorectal and 11 other kinds of cancer that have so-called ‘mismatch repair’ genetic defects, scientists … |